Clinical Trial Update: Pharmacokinetics and Safety of Ertapenem in the Postpartum Period [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics and safety study of ertapenem in the postpartum period for endometritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometritis

Drugs mentioned

• Invanz (ertapenem)

Snippet

Sponsor: Daniel Benjamin | Conditions: Endometritis | Phase 1 | Status: TERMINATED